INPHARMA RESEARCH · DEVELOP PRODUCE
LIVE

Serial Number

79281970

Owner

Inpharma S.p.A.

Attorney

Francesco Braga

Filing Date

Sep 30, 2019

Add to watchlist:

No watchlists yet
View on USPTO

INPHARMA RESEARCH · DEVELOP PRODUCE Trademark

Serial Number: 79281970 • Registration: 6375070

INPHARMA RESEARCH · DEVELOP PRODUCE is a trademark filed by Inpharma S.p.A. on September 30, 2019. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Inpharma S.p.A.

Viale Liguria 20/22

Entity Type: 09

Trademark Details

Filing Date

September 30, 2019

Registration Date

June 8, 2021

Published for Opposition

March 23, 2021

Goods & Services

Foodstuffs and dietetic substances for medical and veterinary purposes, namely, dietary supplements, food grade products being capsules sold empty for pharmaceuticals, infant food for medical purposes, Organic food supplements, organic dietary supplements, powder food supplements, liquid food supplements, dietary supplements that are sold in a container cap for subsequent delivery into liquids, newborn food supplements, infant food supplements, wellness dietary supplements, natural dietary supplements for the treatment of the mental health, nutritionally complete dietetic foods with a standard nutrient formulation adapted for medical purposes, nutritionally complete dietetic foods with a nutrient-adapted formulation specific for a disease, nutritionally incomplete dietetic foods with a standard formulation or a nutrient-adapted formulation specific for a disease; dietetic and nutritional preparations for medical use; infant formula; dietetic substances for babies for medical purposes; dietary supplements for infants; dietary supplements for humans and animals; food supplements; dietary food supplements, not for medical purposes; dietary supplements; nutritional supplements; dietary supplement drink mixes; dietary supplemental drinks; dietetic beverages adapted for medical purposes; multi-vitamin preparations; vitamins and vitamin preparations; dietary supplements for athletes; powdered nutritional supplement drink mix; dietetic foodstuffs for medical purposes, namely, dietary supplements; probiotic supplements; prebiotic supplements; probiotic bacterial formulations for medical use, namely, probiotic supplements; probiotic preparations for medical use to help maintain a natural balance of flora in the digestive system; milk ferments for pharmaceutical purposes; pharmaceutical preparations and substances for treating constipation or diarrhoea; pharmaceutical preparations and substances, namely, Antioxidants, nutritional supplements for boosting energy, Multivitamins, Sleeping pills/tablets, Immunostimulants, oral Rehydration salts, Vitamins, skin Enhancers being medicated skin care preparations, Nasal sprays, Amino acids, Antiemetic preparations, nutritional supplements consisting primarily of iron, Anti-inflammatories, lozenges to relieve sore throat, cough syrups, anti-obesity diet capsules; medicinal preparations and substances for treating constipation or diarrhoea; medicinal preparations and substances, namely, nutritional supplements for boosting energy, Multivitamins, Sleeping pills/tablets, Immunostimulants, oral Rehydration salts, Vitamins, skin Enhancers being medicated skin care preparations, Nasal sprays, Amino acids, Antiemetic preparations, nutritional supplements consisting primarily of iron, Anti-inflammatories, lozenges to relieve sore throat, cough syrups, anti-obesity diet capsules; antibacterial substances for medical purposes; diagnostic substances for medical use; astringents for medical purposes; pharmaceutical antiallergic preparations and substances; bactericides; medical devices based on substances, namely, delivery agents in the form of dissolvable films that facilitate the delivery of nutritional supplements, nasal sprays for cold symptoms, sprays to relieve sore throat

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jun 8, 2026 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Apr 30, 2026 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 24, 2021 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 28, 2021 FICS
FINAL DISPOSITION PROCESSED
Sep 27, 2021 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 8, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
Jun 8, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 23, 2021 NPUB
PUBLISHED FOR OPPOSITION
Mar 23, 2021 PUBO
NOTIFICATION PROCESSED BY IB
Mar 21, 2021 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 3, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Mar 3, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 3, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 18, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 18, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 18, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 18, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 18, 2021 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 9, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 9, 2021 CRFA
ASSIGNED TO LIE
Feb 6, 2021 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 3, 2020 TROA
REFUSAL PROCESSED BY IB
May 23, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 3, 2020 RFCS
REFUSAL PROCESSED BY MPU
May 3, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 22, 2020 RFCR
NON-FINAL ACTION WRITTEN
Apr 21, 2020 CNRT
APPLICATION FILING RECEIPT MAILED
Apr 4, 2020 MAFR
ASSIGNED TO EXAMINER
Mar 31, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 31, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 26, 2020 REPR